The focus of this Center grant application Is to develop small molecule therapeutics targeting filovirus Innate immune antagonists and viral transcription functions. The expectation is that small molecule inhibitors of each target will independently suppress virus replication and exert a therapeutic effect. However, because each inhibitor will have a different mechanism of action and a different target, combinations of inhibitors are expected to exert synergistic antiviral effects. To achieve these goals, we have assembled a team from multiple institutions and diverse backgrounds In filovirus biology. Innate Immunity, structural biology, antiviral drug development and medicinal chemistry. It will be the role of the Administrative Core to provide the necessary oversight, guidance, support and services to ensure the maximal productivity and effective Integration of the efforts of each project and scientific core. The Administrative Core first of all will manage the Center by coordinating financial reporting, submission of progress reports, and other regulatory reports, ensure compliance with regulatory issues, assist with manuscript publication and oversee scientific direction. The latter will include the recruitment of and communication with the scientific advisory board. The Administrative Core will also coordinate participation of project participants to the annual National CETR Program Meeting and a separate annual reverse site visit with NIAID;arrange an Annual Meeting among members of all participating groups, to be held at one of the participating sites;schedule monthly web-based Interlab virtual meetings to exchange ideas and critique data;arrange bi-weekly teleconferences between the Pis and maintain an infrastructure for Web-based resources. Data Management and Data Sharing. To ensure efficient use of the Biosafety Level 4 Core (Core B), which will conduct antiviral testing against Ebola and Marburg viruses, the Administrative Core will provide a formal committee to oversee and ensure efficient use of this Core. Finally, the Administrative Core will oversee and implement a process to solicit, evaluate and recommend Supplemental Research Project applications

Public Health Relevance

): Ebola and Marburg viruses cause a highly lethal hemorrhagic fever and are of concern as potential bioweapons. Core A will provide administrative oversite of this Center so as to promote the development of inhibitors targeting the filovirus innate Immune evasion and transcription functions as anti-filoviral therapies

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
1U19AI109664-01
Application #
8642741
Study Section
Special Emphasis Panel (ZAI1-LR-M (J1))
Project Start
Project End
Budget Start
2014-03-01
Budget End
2015-02-28
Support Year
1
Fiscal Year
2014
Total Cost
$111,527
Indirect Cost
$13,442
Name
Icahn School of Medicine at Mount Sinai
Department
Type
DUNS #
078861598
City
New York
State
NY
Country
United States
Zip Code
10029
Ammosova, Tatyana; Platonov, Maxim; Ivanov, Andrei et al. (2014) 1E7-03, a low MW compound targeting host protein phosphatase-1, inhibits HIV-1 transcription. Br J Pharmacol 171:5059-75
Shabman, Reed S; Jabado, Omar J; Mire, Chad E et al. (2014) Deep sequencing identifies noncanonical editing of Ebola and Marburg virus RNAs in infected cells. MBio 5:e02011
Basler, Christopher F (2014) New hope in the search for Ebola virus treatments. Immunity 41:515-7
Johnson, Joshua C; Martinez, Osvaldo; Honko, Anna N et al. (2014) Pyridinyl imidazole inhibitors of p38 MAP kinase impair viral entry and reduce cytokine induction by Zaire ebolavirus in human dendritic cells. Antiviral Res 107:102-9
Xu, Wei; Edwards, Megan R; Borek, Dominika M et al. (2014) Ebola virus VP24 targets a unique NLS binding site on karyopherin alpha 5 to selectively compete with nuclear import of phosphorylated STAT1. Cell Host Microbe 16:187-200
Kumari, Namita; Iordanskiy, Sergey; Kovalskyy, Dmytro et al. (2014) Phenyl-1-Pyridin-2yl-ethanone-based iron chelators increase I?B-? expression, modulate CDK2 and CDK9 activities, and inhibit HIV-1 transcription. Antimicrob Agents Chemother 58:6558-71
Basler, Christopher F; Woo, Patrick C Y (2014) Editorial overview: emerging viruses. Curr Opin Virol 5:v-vii
Ilinykh, Philipp A; Tigabu, Bersabeh; Ivanov, Andrey et al. (2014) Role of protein phosphatase 1 in dephosphorylation of Ebola virus VP30 protein and its targeting for the inhibition of viral transcription. J Biol Chem 289:22723-38
Basler, Christopher F (2014) Portrait of a killer: genome of the 2014 EBOV outbreak strain. Cell Host Microbe 16:419-21
Feagins, Alicia R; Basler, Christopher F (2014) The VP40 protein of Marburg virus exhibits impaired budding and increased sensitivity to human tetherin following mouse adaptation. J Virol 88:14440-50